Navigation überspringen Sitemap anzeigen

Oncology-Products

Astro Pharma has been active in the field of oncology products for a long time. Our oncology products have a wide range of applications spanning oncology, hematology and dermatology.

With the two biosimilars Herzuma® and Truxima®, Astro Pharma benefits from its many years of experience with high-quality follow-on products from biologics and thus contributes to an expansion of therapeutic options as well as security of supply.

Areas of application are mainly non-Hodgkin's lymphoma, chronic lymphocytic leukemia and HER2 positive breast cancer.

Astro Pharma has been marketing the hedgehog inhibitor Odomzo® since November 2020. This is used in adults with locally advanced basal cell carcinoma for whom curative surgery or radiotherapy are not an option.


Product name Active component
Herzuma® 150 mg powder for concentrate for solution for infusion Trastuzumab
Herzuma® 420 mg powder for concentrate for solution for infusion Trastuzumab
Odomzo 200 mg hard capsules Sonidegib
DocCheck"Pregnancy Prevention Program" Info
only allow registered users to view
DocCheck
Login
Truxima® 100 mg concentrate for solution for infusion Rituximab
DocCheck"Educational Material" Info
only allow registered users to view
DocCheck
Login
Truxima® 500 mg concentrate for solution for infusion Rituximab
DocCheck"Educational Material" Info
only allow registered users to view
DocCheck
Login

The Package leaflet can be found on the website of the European Medicines Agency (EMA). If you have any questions about the oncologicals from Astro Pharma, please contact .

Here you will find the conditions for the exchange and return of medicines:

Return conditions (only in German)
Zum Seitenanfang